ZEVTERA
Generic: ceftobiprole medocaril sodium
- Manufacturer
- Basilea
- NDC
- 68547-578
- RxCUI
- 2703561
- Route
- INTRAVENOUS
- ICD-10 indication
- J18.9
Affordability Check
How much will you actually pay for ZEVTERA?
In 30 seconds, see every legitimate way to afford ZEVTERA — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About ZEVTERA
What is this medication? ZEVTERA, which contains the active ingredient ceftobiprole medocaril sodium, is an injectable cephalosporin antibiotic used to treat several types of serious bacterial infections. It is approved for use in adults and, for certain conditions, pediatric patients. This medication works by disrupting the ability of bacteria to create their cell walls, which eventually causes the bacteria to die and helps the body clear the infection. It is effective against a broad range of bacteria, including some strains that have developed resistance to other common antibiotics.
The primary uses for ZEVTERA include treating Staphylococcus aureus bloodstream infections, also known as bacteremia, in adults. It is also indicated for the treatment of acute bacterial skin and skin structure infections in adults and community-acquired bacterial pneumonia in both adults and children as young as three months old. Because it is administered through an intravenous infusion, it is typically given by healthcare providers in a hospital or clinical setting to manage these severe or complex bacterial conditions.
Copay & patient assistance
Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for ceftobiprole medocaril sodium.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup ZEVTERA →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for ceftobiprole medocaril sodium →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Medicare Part D coverage
How ZEVTERA appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).
Covered by plans
1%
33 of 5,499 plans
Most common tier
Tier 5
On 67% of covering formularies
Prior authorization required
33%
of covering formularies
| Tier | Formularies on this tier | Share |
|---|---|---|
| Tier 2 (generic) | 1 | 33% |
| Tier 5 (specialty) | 2 | 67% |
Step therapy: 0% of formularies
Quantity limits: 0% of formularies
Coverage breadth: 3 of 65 formularies
How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | Yes | — | — |
Related drugs
METRONIDAZOLE
Treats same condition · Metronidazole
Tigecycline
Treats same condition · Tigecycline
RECARBRIO
Treats same condition · imipenem anhydrous, cilastatin, and relebactam anhydrous
Aztreonam
Treats same condition · AZTREONAM
AZACTAM
Treats same condition · AZTREONAM
TYZAVAN
Treats same condition · Vancomycin
Atovaquone
Treats same condition · Atovaquone
FLUCONAZOLE
Treats same condition · Fluconazole
Ery-Ped
Treats same condition · Erythromycin Ethylsuccinate
CEFDINIR
Treats same condition · Cefdinir
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.
Rare-disease navigation (specialists, trials, patient communities)
ZEVTERA treats a rare condition. For in-depth disease pages on our sister site:
UniteRare.org is our sister site for rare-disease navigation — same editorial team, same accuracy standards.